The Role of Diagnostics in HPV Screening

The Importance of HPV Screening

Human papillomavirus (HPV) is a common sexually transmitted infection that is linked to the development of cervical cancer. The primary screening for HPV infection is an important tool in the prevention of cervical cancer, as it enables the identification of individuals who are at increased risk for the disease. However, it is crucial to ensure the accuracy and reliability of molecular diagnostic methods used for HPV primary screening, through quality control measures.

Factors affecting reliability and accuracy

Molecular diagnostic methods, such as polymerase chain reaction (PCR), are used for HPV primary screening, as they enable the detection of viral DNA in cervical samples with high sensitivity and specificity. However, the accuracy and reliability of these methods can be affected by several factors, including the quality of the sample, the presence of inhibitors, and the specificity of the primers used for the PCR reaction.

Quality Control measures

To ensure the accuracy and reliability of molecular diagnostic methods used for HPV primary screening, quality control measures are essential. These measures include the use of appropriate positive and negative controls, to verify the performance of the assay, and the use of standardized protocols and reagents, to ensure consistency and reproducibility of the results. In addition, regular monitoring of the performance of the assay, through proficiency testing and external quality assessment schemes, can provide assurance of the accuracy and reliability of the results.

Accurate and reliable diagnostics

The importance of HPV primary screening and quality control of molecular diagnostic methods used for this cannot be overstated, as the accuracy of the screening results can impact patient management and treatment decisions. Early detection of HPV infection through primary screening, followed by appropriate management and treatment, can prevent the development of cervical cancer and improve patient outcomes. Therefore, it is essential to ensure the accuracy and reliability of molecular diagnostic methods used for HPV primary screening, through quality control measures, to maximize the benefits of this screening approach in the prevention of cervical cancer.

Microbix’s approach to HPV Screening

Microbix is proud to offer External Quality Controls & RUO (QAPs™) for HPV Molecular and Immunoassay Diagnostics. 

– Whole-process samples (including extraction). 

– Inactivated to meet clinical laboratory biosafety requirements and verified performance on leading IVD platforms. 

– They are also commutable and cross-platform compatible. 

– The 1mL vials are stable at 2-8°C, making storage easy. 

Contact us to learn more or place an order on our HPV panel.